PharmaVoice Nov 24, 2025 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers
PharmaVoice Nov 19, 2025 As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones #MASH rivals #faces MASH
PharmaVoice Nov 18, 2025 Amylin could reign supreme in the next wave of obesity drugs #weight management #critical readouts
PharmaVoice Nov 17, 2025 The next leap in Alzheimer’s R&D is coming, but not around the corner #couple drugs #true paradigm